PD-1 inhibitor (anti-PD-1 therapy)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PD-1 inhibitor (anti-PD-1 therapy), covering 2018-07-27 to 2025-12-01. Get the full timeline:
Most recent: Clinical Trial Update: Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation [Phase 2]